Lukas Hainz sits down with Ivan Kairatov, a distinguished biopharma expert with a deep background in research and development and a keen eye for technological innovation within the pharmaceutical industry. Together, they explore a recent breakthrough from the University of Cambridge that reimagines
Ivan Kairatov is a leading biopharma and public health expert with extensive experience in research and development, particularly focusing on how technological innovation can be leveraged to combat infectious diseases. With a career spanning over a decade, he has become a pivotal voice in the
In a world grappling with the compounding pressures of global conflict and environmental disasters, the very foundation of public health is being tested, revealing deep-seated inequities that threaten our collective future. The challenge is no longer merely about treating disease but about
The National Health Service (NHS) in the UK faces a pivotal moment where strategic inward investment could redefine healthcare delivery and economic vitality, especially in Wales, a region grappling with unique challenges and brimming with potential. With escalating patient demand, persistent
In an era where healthcare systems face unprecedented challenges, from rising costs to complex patient needs, clinical pharmacists have emerged as vital contributors to improving medical quality on a global scale, with their expertise extending far beyond the traditional role of dispensing
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research, development, and innovation has positioned him as a thought leader in the cell and gene therapy (CGT) industry. With a sharp focus on emerging technologies and strategic growth, Ivan
